GanD, Inc. — Department of Defense SBIR Phase II: DHA172-009
GanD, Inc. — SBIR Phase II award from Department of Defense.
- Amount
- $1,000,000
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase II
- Topic
- DHA172-009
- Solicitation
- 17.2
- NAICS
- —
- Place of performance
- FL
- Period
- 2019-05-13 → 2021-04-12
Description
Problem: Currently available resuscitation fluids have been shown to induce detrimental effects on trauma outcomes. Objective: The objective of this proposal is to use the data from the successful Phase 1 studies to guide the continued development and te